AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese Medicine
AISTCM-The Pathological Pattern Differentiation and Outcome Measurement of Acute Ischemic Stroke Treated With Traditional Chinese Medicine
Sponsor: Guangzhou University of Traditional Chinese Medicine
Listed as NCT00351806, this PHASE4 trial focuses on Cerebral Infarction and remains completed. Sponsored by Guangzhou University of Traditional Chinese Medicine, it has been updated 6 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Jul 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Guangzhou University of Traditional Chinese Medicine
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Beijing, China , Chengdu, China , Foshan, China , Guangzhou, China , Hangzhou, China , Jinan, China , Nanning, China , Shanghai, China , Taizhou, China , Wenzhou, China and 5 more locations